United States · FDA National Drug Code directory

Olmesartan Medoxomil and Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70756-814_45806c19-480f-987e-e063-6394a90aa8fa
Product NDC: 70756-814
Form: TABLET
Composition / generic term: Olmesartan Medoxomil and Hydrochlorothiazide
Labeler: Lifestar Pharma LLC
Marketing category: ANDA
Marketing start / end (source format): 20201001
Source listing expiry: 20261231

Source-listed ingredients

OLMESARTAN MEDOXOMIL — 40 mg/1
HYDROCHLOROTHIAZIDE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1000 TABLET in 1 BOTTLE (70756-814-12) · 70756-814-12
30 TABLET in 1 BOTTLE (70756-814-30) · 70756-814-30
500 TABLET in 1 BOTTLE (70756-814-51) · 70756-814-51
90 TABLET in 1 BOTTLE (70756-814-90) · 70756-814-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →